ATOSSA THERAPEUTICS, INC. (ATOS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$3.43M2012: -$5.07M2013: -$10.78M2014: -$12.17M2015: -$12.76M2016: -$7.97M2017: -$7.65M2018: -$11.43M2019: -$17.27M2020: -$14.61M2021: -$20.52M2022: -$27.69M2023: -$31.38M2024: -$27.62M2025: -$37.14M-$37.14M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$37.14M-34.5%
2024-$27.62M+12.0%
2023-$31.38M-13.3%
2022-$27.69M-34.9%
2021-$20.52M-40.5%
2020-$14.61M+15.4%
2019-$17.27M-51.0%
2018-$11.43M-49.5%
2017-$7.65M+4.0%
2016-$7.97M+37.5%
2015-$12.76M-4.8%
2014-$12.17M-12.9%
2013-$10.78M-112.8%
2012-$5.07M-47.8%
2011-$3.43M